Academic literature on the topic 'Vaginal Candidiasis Vulvovaginitis Diabetes Mellitus'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Vaginal Candidiasis Vulvovaginitis Diabetes Mellitus.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Vaginal Candidiasis Vulvovaginitis Diabetes Mellitus"

1

Kravchenko, О. V. "Problematic issues of diagnosis and treatment of vulvovaginitis of mixed bacterial-candidiasis etiology." Reproductive Endocrinology, no. 57 (March 31, 2021): 43–46. http://dx.doi.org/10.18370/2309-4117.2021.57.43-46.

Full text
Abstract:
The aim of the study is to evaluate the effectiveness of modern antiseptic agent Gynodek in the treatment of mixed bacterial-candidiasis vulvovaginitis.Materials and methods. There were 67 patients with bacterial-candidiasis vulvovaginitis under observation. The diagnosis of candidiasis infection was verified according to the data of clinical and laboratory research methods. Patients received vaginal gel Gynodek 5 ml once a day for 7 days. The effectiveness of treatment was assessed according to the data of the clinical examination before treatment and on the 7th day of observation, and accord
APA, Harvard, Vancouver, ISO, and other styles
2

S, Agarwal, Jafar H, Tiwari S, and Prakash V. "Etiological profile and risk factors of vulvovaginitis among women of reproductive age in a tertiary care hospital in northern India." Journal of Medical and Scientific Research 13, no. 2 (2025): 177–82. https://doi.org/10.17727/jmsr.2024/13-31.

Full text
Abstract:
Background: Vulvovaginitis is a common condition affecting women of reproductive age, characterized by vaginal discharge, itching, and discomfort. It can be caused by bacterial, fungal, or protozoal infections. Despite its high prevalence, vulvovaginitis often remains under-reported in India due to social stigma and lack of awareness. Accurate identification of the etiological agents and associated risk factors is essential for planning effective treatment and prevention strategies. This study aimed to identify the causative agents of vulvovaginitis and evaluate associated risk factors among w
APA, Harvard, Vancouver, ISO, and other styles
3

Kosei, N. V., S. I. Reheda, M. I. Hlamazda, and L. A. Vasylchenko. "Current opportunities for treatment and prevention of recurrent vulvovaginitis in reproductive aged women." REPRODUCTIVE ENDOCRINOLOGY, no. 61 (November 25, 2021): 77–82. http://dx.doi.org/10.18370/2309-4117.2021.61.77-82.

Full text
Abstract:
Vulvovaginal candidiasis is an urgent medical and social problem, a common reason for women to see a doctor. This disease occurs in women of different ages, which leads to a significant decrease in the quality of life, and to more serious complications in some cases (genitourinary system diseases, miscarriage, vaginal stenosis, etc.).Research objective. Comprehensive assessment of the effectiveness of treatment and prevention of recurrent vulvovaginal candidiasis (RVVC) with Candivac (contains inactivated microorganisms in the form of frozen lyophilized 4 original strains, which are the most c
APA, Harvard, Vancouver, ISO, and other styles
4

Kravchenko, О. V. "Preserving reproductive health before the first pregnancy." REPRODUCTIVE ENDOCRINOLOGY, no. 63-64 (May 27, 2022): 47–52. http://dx.doi.org/10.18370/2309-4117.2022.63.47-52.

Full text
Abstract:
Research objective: to evaluate the effectiveness of drugs based on decamethoxine for the treatment of inflammatory diseases of genital organs in adolescent girls entering reproductive age.Materials and methods. The study included 96 patients aged 17–19 years who lived an irregular sexual life. The diagnosis of vulvovaginal infection was verified based on clinical and laboratory data. All patients with vulvovaginal infection received Decasan solution 50–100 ml three times a day in the form of irrigation of the external genitalia for the daytime sanitation and Gynodek vaginal gel 5 ml once at n
APA, Harvard, Vancouver, ISO, and other styles
5

Bala, Madhu, Rajni Raj Kumar, Shagufta Magsi, Sabahat Fatima, Nadia Nawaz, and Usha Ashok. "Evaluation of Prevalence of Vaginal Candidiasis and Related Risk Factors: A Cross Sectional Study." Pakistan Journal of Medical and Health Sciences 16, no. 1 (2022): 604–7. http://dx.doi.org/10.53350/pjmhs22161604.

Full text
Abstract:
Aim: The study aims to evaluate the prevalence of vaginal candidiasis and associated risk factors Study design: Cross sectional study Place and duration: This study was conducted in Muhammad Medical and Dental College Mirpurkhas, Pakistan from March 2020 to March 2021. Methodology: The present study includes a total of 216 participants who had presented with symptoms of vaginal candidiasis. During this whole duration, 1800 patients visited the department. The laboratory investigations used in this regard were Gram-stained smears, vaginal cultures, and wet mount microscopy. Evaluation of risk f
APA, Harvard, Vancouver, ISO, and other styles
6

Calin, Alina Mihaela, Aurel Nechita, Ana Magdalena Bratu, et al. "POSSIBILITIES OF GYNECOLOGICAL DRUG TREATMENTS IN VAGINAL AND VULVAR CANDIDIASIS CAUSED BY DIABETES ASSOCIATED WITH ORAL PATHOLOGY." Romanian Journal of Oral Rehabilitation 16, no. 1 (2024): 587–89. https://doi.org/10.62610/rjor.2024.1.16.57.

Full text
Abstract:
This review aims to evaluate efficacy and drug treatment options in cases of vaginal and vulvar candidiasis associated with diabetes. We conducted an exhaustive literature review, looking at relevant clinical trials, meta-analyses, and clinical experiences. Patients with candidiasis and diabetes mellitus were included in a clinical case study to assess their response to treatment. Antifungals such as fluconazole and clotrimazole have been effective in treating candidiasis, but success has been influenced by glucose control levels. Proper diabetes management, along with antifungal therapy, resu
APA, Harvard, Vancouver, ISO, and other styles
7

Suharti, Netti, Anon Almudri, Ricvan Dana Nindrea, and Silfina Indriani. "Association of Diabetes Mellitus and Estrogen Hormone Levels with Vaginal Candidiasis." Indian Journal of Public Health Research & Development 11, no. 1 (2020): 1305. http://dx.doi.org/10.37506/v11/i1/2020/ijphrd/194023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Grigorian, O. R., and E. N. Andreeva. "The use of estriol for the treatment of atrophic vulvovaginitis in women with disturbances of carbohydrate metabolism in the peri- and postmenopausal period." Problems of Endocrinology 57, no. 2 (2011): 27–31. http://dx.doi.org/10.14341/probl201157227-31.

Full text
Abstract:
Specific urogenital tract symptoms in women with diabetes mellitus are shown to directly correlate with the quality of compensation of carbohydrate metabolism while atrophic vulvovaginitis is both a consequence and an early marker of its decompensation. It is concluded that combined patogenetically sound treatment of acute and chronic "atrophic diabetic vulvitis" in patients presenting with disturbances of carbohydrate metabolism in the peri- and postmenopausal period should include Estrocard therapy, apart from thorough compensation of carbohydrate metabolism, in order to normalize the vagina
APA, Harvard, Vancouver, ISO, and other styles
9

G.Zh., Sakhipova, Akhmetova S.Zh., Kanguzhieva K.K., and Akhmetova K.A. "FEATURES OF THE COLPOSCOPIC PICTURE IN WOMEN WITH DIABETES MELLITUS." Farmaciâ Kazahstana, no. 5 (November 21, 2024): 94–102. http://dx.doi.org/10.53511/pharmkaz.2024.30.73.011.

Full text
Abstract:
diabetes mellitus predisposes people to bacterial and fungal infections, including those caused by Candida species. According to researchers, the frequency of detection of vulvovaginal candidiasis is higher in patients with diabetes than in other diseases [13,14]. In addition, chronic recurrent vulvovaginal candidiasis can be a marker of diabetes mellitus [15,6]. Factors such as antibiotic therapy, taking corticosteroids and other immunosuppressants, and atopic dermatitis also predispose to genital fungal infections. Diabetes mеllіtus is a multisystem disease that affects the female genitourin
APA, Harvard, Vancouver, ISO, and other styles
10

Weerasekera, Manjula Manoji, TD Chinthika P. Gunasekara, Janani Kottachchi, Tishani Methsela Wijesuriya, and Achala Bogahawatta. "Vulvovaginal Candidiasis in Patients presenting with Vaginal Discharge in a Sri Lankan Setting." Journal of South Asian Federation of Obstetrics and Gynaecology 8, no. 2 (2016): 123–26. http://dx.doi.org/10.5005/jp-journals-10006-1400.

Full text
Abstract:
ABSTRACT Background Vulvovaginal candidiasis (VVC) is a common infection among women. Due to the emerging role of nonalbicans Candida in VVC, it is important to periodically investigate the proportions of infection caused by different Candida species and antifungal resistance patterns. Aims This study aims to determine the frequency of occurrence of VVC in women presenting with vaginal discharge, possible risk factors associated with the disease, and antifungal susceptibility pattern of the isolates of Candida. Materials and methods High vaginal swabs from 158 women presenting with vaginal dis
APA, Harvard, Vancouver, ISO, and other styles
More sources

Conference papers on the topic "Vaginal Candidiasis Vulvovaginitis Diabetes Mellitus"

1

Medeiros, Fernanda Salvador, João Victor Venâncio Braga, Raíssa Cardoso Antônio, Maria Luiza dos Santos Nunes, Ana Carolina de Moura Traverso, and Thales Seabra Fernandes. "Eficácia das abordagens terapêuticas para candidíase vulvovaginal recorrente: uma revisão sistematizada." In Resumos do 48º Congresso de ginecologia e obstetrícia. Zeppelini Editorial e Comunicação, 2024. https://doi.org/10.5327/jbg-2965-3711-2024134s1049.

Full text
Abstract:
Objetivo: Realizar uma revisão sistematizada dos anos de 2014–2024 acerca das terapias utilizadas no tratamento da candidíase vulvovaginal recorrente (CVVR) para avaliar sua eficácia e seus desafios. Fontes de dados: Pesquisa bibliográfica nas bases United States National Library of Medicine (PubMed), Scientific Electronic Library Online (SciELO) e Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS). Seleção de estudos: Os descritores escolhidos nos Descritores em Ciência de Saúde (DeCS) foram: “vulvovaginal candidiasis AND recurrence AND therapeutics”. Os critérios de inclus
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!